Medical device commissioning gross margin

35%. According to the search Sohu.com shows that in 2022, the company's related business revenue expanded significantly; Boji Medicine, Tiger Pharmaceuticals, WuXi KangDe, KangLongHuaCheng are all comprehensive enterprises that lay out the drug CRO and medical device CRO, and the gross profit rate of the medical device CRO business has stabilized at about 35%.